BE629171A - - Google Patents

Info

Publication number
BE629171A
BE629171A BE629171A BE629171A BE629171A BE 629171 A BE629171 A BE 629171A BE 629171 A BE629171 A BE 629171A BE 629171 A BE629171 A BE 629171A BE 629171 A BE629171 A BE 629171A
Authority
BE
Belgium
Application number
BE629171A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US177169A external-priority patent/US3072642A/en
Priority claimed from US177169A external-priority patent/US3072639A/en
Priority claimed from US177169A external-priority patent/US3072641A/en
Priority claimed from US177169A external-priority patent/US3072640A/en
Application filed filed Critical
Publication of BE629171A publication Critical patent/BE629171A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005Ketals
    • C07J21/006Ketals at position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/0026Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031Oxygen-containing hetero ring cyclic ketals at positions 16, 17
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036Nitrogen-containing hetero ring
    • C07J71/0042Nitrogen only
    • C07J71/0047Nitrogen only at position 2(3)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
BE629171A 1962-03-05 1963-03-04 BE629171A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US177169A US3072642A (en) 1962-03-05 1962-03-05 16-oxygenated-4-pregneno-[3, 2-c] pyrazoles and process of preparing them
US177169A US3072639A (en) 1962-03-05 1962-03-05 16-oxygenated-4-pregneno-[3, 2-c] pyrazoles and process of preparing them
US177169A US3072641A (en) 1962-03-05 1962-03-05 16-oxygenated-4-pregneno-[3, 2-c] pyrazoles and process of preparing them
US177169A US3072640A (en) 1962-03-05 1962-03-05 16-oxygenated-4-pregneno-[3, 2-c] pyrazoles and process of preparing them

Publications (1)

Publication Number Publication Date
BE629171A true BE629171A (ja) 1963-09-04

Family

ID=27497228

Family Applications (1)

Application Number Title Priority Date Filing Date
BE629171A BE629171A (ja) 1962-03-05 1963-03-04

Country Status (7)

Country Link
BE (1) BE629171A (ja)
BR (1) BR6347344D0 (ja)
CH (1) CH454843A (ja)
DE (1) DE1468243A1 (ja)
FI (1) FI40461B (ja)
FR (1) FR3086M (ja)
GB (1) GB1030304A (ja)

Also Published As

Publication number Publication date
FR3086M (fr) 1965-02-26
DE1468243A1 (de) 1969-07-24
FI40461B (ja) 1968-10-31
BR6347344D0 (pt) 1973-08-28
CH454843A (de) 1968-04-30
GB1030304A (en) 1966-05-18

Similar Documents

Publication Publication Date Title
FI40461B (ja)
BE614757A (ja)
BE632620A (ja)
AU269855A (ja)
AU480751A (ja)
BE380301A (ja)
BE634968A (ja)
BE489310A (ja)
BE538252A (ja)
BE538831A (ja)
BE541929A (ja)
BE553896A (ja)
BE559145A (ja)
BE586180A (ja)
BE592434A (ja)
BE599783A (ja)
BE604335A (ja)
BE608197A (ja)
BE609543A (ja)
BE612190A (ja)
BE612311A (ja)
BE612464A (ja)
BE612847A (ja)
BE612926A (ja)
BE613108A (ja)